Simpleware ScanIP Medical has CE Marking, FDA 510(k) marketing clearance, and ISO 13485:2016 certification.
FDA 510(k) Premarket Notification
Please note that only the Simpleware ScanIP Medical edition is available for the below Indications for Use.
Simpleware ScanIP Medical has CE Marking, FDA 510(k) marketing clearance, and ISO 13485:2016 certification.
FDA 510(k) Premarket Notification
Please note that only the Simpleware ScanIP Medical edition is available for the below Indications for Use.
'Simpleware ScanIP is intended for use as a software interface and image segmentation system for the transfer of imaging information from a medical scanner such as a CT scanner or an MRI scanner to an output file. It is also intended as pre-operative software for simulating/evaluating surgical treatment options. ScanIP is not intended to be used for mammography imaging.'
The general version of Simpleware ScanIP is intended only for research purposes. It is intended to be used for visualization, analysis and model generation of a variety of imaging formats, including for biomedical research. However, this version must not be used, and is not intended to be used, for any medical or clinical purpose whatsoever.
The CE marking is currently applicable in the following countries:
Belgium, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Hungary, Iceland, Luxembourg, Malta, Netherlands, Poland, Slovenia, Switzerland, United Kingdom
The Instructions for Use (IFU) for Simpleware ScanIP is available to download in an electronic format:
Minimum requirements for viewing IFU:
Instructions for Use in Other Languages:
Version History:
The first Instructions for Use was issued for the Simpleware N-2018.03 release, prior to CE marking.*
The current release is P-2019.09
*Please note that the first Instructions for Use for non-English languages begin from O-2018.12.
Past Instructions for Use:
Simpleware ScanIP DICOM Conformance Statement